Dermime S - Search Results

1

Dermime S, Armstrong A, Hawkins RE, Stern PL. Dermime S, et al. Br Med Bull. 2002;62:149-62. doi: 10.1093/bmb/62.1.149. Br Med Bull. 2002. PMID: 12176857 Review.

2

Developing effective cancer vaccines: design and monitoring are critical.

Armstrong A, Dermime S. Armstrong A, et al. Among authors: dermime s. Br J Cancer. 2001 Jun 1;84(11):1433-6. doi: 10.1054/bjoc.2001.1839. Br J Cancer. 2001. PMID: 11384088 Free PMC article. No abstract available.

3

Immunization with a recombinant adenovirus encoding a lymphoma idiotype: induction of tumor-protective immunity and identification of an idiotype-specific T cell epitope.

Armstrong AC, Dermime S, Allinson CG, Bhattacharyya T, Mulryan K, Gonzalez KR, Stern PL, Hawkins RE. Armstrong AC, et al. Among authors: dermime s. J Immunol. 2002 Apr 15;168(8):3983-91. doi: 10.4049/jimmunol.168.8.3983. J Immunol. 2002. PMID: 11937555

4

Adoptive transfer of anti-idiotypic T cells cure mice of disseminated B cell lymphoma.

Armstrong AC, Dermime S, Mulryan K, Stern PL, Bhattacharyya T, Hawkins RE. Armstrong AC, et al. Among authors: dermime s. J Immunother. 2004 May-Jun;27(3):227-31. doi: 10.1097/00002371-200405000-00007. J Immunother. 2004. PMID: 15076140

5

Vaccine and antibody-directed T cell tumour immunotherapy.

Dermime S, Gilham DE, Shaw DM, Davidson EJ, Meziane el-K, Armstrong A, Hawkins RE, Stern PL. Dermime S, et al. Biochim Biophys Acta. 2004 Jul 6;1704(1):11-35. doi: 10.1016/j.bbcan.2004.03.002. Biochim Biophys Acta. 2004. PMID: 15238242 Review.

6

Use of adenoviruses encoding CD40L or IL-2 against B cell lymphoma.

Meziane el K, Bhattacharyya T, Armstrong AC, Qian C, Hawkins RE, Stern PL, Dermime S. Meziane el K, et al. Among authors: dermime s. Int J Cancer. 2004 Oct 10;111(6):910-20. doi: 10.1002/ijc.20332. Int J Cancer. 2004. PMID: 15300803

7

CD8 T-cell recognition of human 5T4 oncofetal antigen.

Smyth LJ, Elkord E, Taher TE, Jiang HR, Burt DJ, Clayton A, van Veelen PA, de Ru A, Ossendorp F, Melief CJ, Drijfhout JW, Dermime S, Hawkins RE, Stern PL. Smyth LJ, et al. Among authors: dermime s. Int J Cancer. 2006 Oct 1;119(7):1638-47. doi: 10.1002/ijc.22018. Int J Cancer. 2006. PMID: 16646078

8

NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives.

Thomas R, Al-Khadairi G, Roelands J, Hendrickx W, Dermime S, Bedognetti D, Decock J. Thomas R, et al. Among authors: dermime s. Front Immunol. 2018 May 1;9:947. doi: 10.3389/fimmu.2018.00947. eCollection 2018. Front Immunol. 2018. PMID: 29770138 Free PMC article. Review.

9

Unleashing the immune response to NY-ESO-1 cancer testis antigen as a potential target for cancer immunotherapy.

Raza A, Merhi M, Inchakalody VP, Krishnankutty R, Relecom A, Uddin S, Dermime S. Raza A, et al. Among authors: dermime s. J Transl Med. 2020 Mar 27;18(1):140. doi: 10.1186/s12967-020-02306-y. J Transl Med. 2020. PMID: 32220256 Free PMC article. Review.

10

The role of PAK4 in the immune system and its potential implication in cancer immunotherapy.

Naїja A, Merhi M, Inchakalody V, Fernandes Q, Mestiri S, Prabhu KS, Uddin S, Dermime S. Naїja A, et al. Among authors: dermime s. Cell Immunol. 2021 Sep;367:104408. doi: 10.1016/j.cellimm.2021.104408. Epub 2021 Jul 1. Cell Immunol. 2021. PMID: 34246086 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

103 results

Search Page

Filters